Revance Therapeutics Accounts Payable (Quarterly) Analysis

Revance Therapeutics Inc (RVNC)

5.36 -0.03 (-0.56%) USD | NASDAQ | Sep 27, 16:00

5.355 0.00 (0.00%) After-Hours: 20:00

Accounts Payable (Quarterly) Chart

Historical Accounts Payable (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
June 30, 2024	4.985M
March 31, 2024	5.276M
December 31, 2023	13.81M
September 30, 2023	4.775M
June 30, 2023	8.345M
March 31, 2023	13.00M
December 31, 2022	4.546M
September 30, 2022	0.744M
June 30, 2022	13.27M
March 31, 2022	10.02M
December 31, 2021	10.60M
September 30, 2021	8.038M
June 30, 2021	8.176M
March 31, 2021	7.079M
December 31, 2020	12.66M
September 30, 2020	7.86M
June 30, 2020	6.603M
March 31, 2020	8.709M
December 31, 2019	8.01M
September 30, 2019	6.902M
June 30, 2019	7.966M
March 31, 2019	4.486M
December 31, 2018	8.434M

Date	Value
September 30, 2018	7.341M
June 30, 2018	5.435M
March 31, 2018	5.361M
December 31, 2017	6.805M
September 30, 2017	6.68M
June 30, 2017	4.079M
March 31, 2017	5.573M
December 31, 2016	3.754M
September 30, 2016	2.871M
June 30, 2016	2.982M
March 31, 2016	3.307M
December 31, 2015	2.657M
September 30, 2015	2.731M
June 30, 2015	2.211M
March 31, 2015	2.089M
December 31, 2014	3.149M
September 30, 2014	2.666M
June 30, 2014	2.687M
March 31, 2014	3.689M
December 31, 2013	5.526M
September 30, 2013	10.05M
December 31, 2012	1.805M

Accounts Payable Definition

Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.

Read full definition.

Accounts Payable (Quarterly) Range, Past 5 Years

0.744M

Minimum

Sep 2022

13.81M

Maximum

Dec 2023

8.170M

Average

8.024M

Median

Accounts Payable (Quarterly) Benchmarks